{"id":"clm_ABFE2CB3CF48","entity":"gilead-sciences","predicate":"revenue","value":"27,116,000,000 United States dollar","value_json":{"fy":2023,"accn":"0000882095-24-000007","form":"10-K","filed":"2024-02-23","concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"},"valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Gilead Sciences revenue: 27,116,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_ABFE2CB3CF48, https://asof.is/claim/clm_ABFE2CB3CF48, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209524000007/0000882095-24-000007-index.htm.","url":"https://asof.is/claim/clm_ABFE2CB3CF48","accessed":"2026-11-08"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_766F0DC2656D","supersedes":["clm_63D857B5C382"],"first_seen_at":"2026-11-08T15:39:30.122293+00:00","updated_at":"2026-11-08T15:39:38.15326+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209524000007/0000882095-24-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-23T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2023, filed 2024-02-23"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}